Showing results (171-180 of 234) with videos related to
Sort By:
Pageof 24
RNA (New York, N.Y.)|May 19, 2019
A piggyBac-based toolkit for inducible genome editing in mammalian cellsMegan D Schertzer, Eliza Thulson, Keean C A Braceros, et al.The Journal of Bone and Joint Surgery. American Volume|January 26, 2021
Partial Distal Biceps Avulsion Results in a Significant Loss of Supination ForceYoshiaki Tomizuka, Christopher C Schmidt, Anthony J Davidson, et al.Molecular Biology of the Cell|February 2, 2022
Quantification of microtubule stutters: dynamic instability behaviors that are strongly associated with catastropheShant M Mahserejian, Jared P Scripture, Ava J Mauro, et al.Biorxiv : the Preprint Server for Biology|May 22, 2023
Ectopically expressed Airn lncRNA deposits Polycomb with a potency that rivals XistJackson B Trotman, Aki K Braceros, Steven R Bischoff, et al.Leukemia & Lymphoma|June 23, 2025
Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITYMichael J Mauro, Rüdiger Hehlmann, Loretta A Williams, et al.Leukemia & Lymphoma|March 27, 2019
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysisJesus G Berdeja, Michael C Heinrich, Shaker R Dakhil, et al.British Journal of Cancer|January 6, 2011
Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancerJ B Baker, D Dutta, D Watson, et al.Cancer Research|July 9, 2009
Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in miceDavid Surguladze, Dhanvanthri Deevi, Nidia Claros, et al.American Journal of Hematology|October 6, 2018
Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITYRüdiger Hehlmann, Jorge E Cortes, Teresa Zyczynski, et al.The Journal of Clinical Endocrinology and Metabolism|March 23, 2021
Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube ModelsLaura J Mauro, Megan I Seibel, Caroline H Diep, et al.Pageof 24